Sotera Health Company

NASDAQ:SHC

16.74 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 276.594248.176310.239263.177255.282220.59251.59248.704266.639236.754241.249226.164251.917212.148216.845200.028213.085188.2193.485195.322194.76194.76
Cost of Revenue 139.22136.793145.857117.193115.694109.087109.87112.691116.243107.879107.296100.578108.15696.77696.26892.51794.11891.68396.26495.07895.77795.777
Gross Profit 137.374111.383164.382145.984139.588111.503141.72136.013150.396128.875133.953125.586143.761115.372120.577107.511118.96796.51797.221100.24498.98398.983
Gross Profit Ratio 0.4970.4490.530.5550.5470.5050.5630.5470.5640.5440.5550.5550.5710.5440.5560.5370.5580.5130.5020.5130.5080.508
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 0000000000000053.15600037.1244.45700
Selling & Marketing Expenses 0000000000000000000000
SG&A 52.16451.81639.74454.11260.28761.9165.94957.09163.13259.54251.82744.03849.82852.46553.15645.63242.68437.05337.1244.45731.85631.856
Other Expenses 1.52-0.9614.072-0.4272.47416.22715.60315.727-0.48515.8417.8540.6932.7643.895.063.1454.358-3.152.5-0.16200
Operating Expenses 52.16451.81639.74469.88676.38478.13781.55272.81878.90175.38367.52759.91565.48969.00868.19660.48157.22551.65251.7458.89545.68845.688
Operating Income 85.2159.567124.63876.09863.20433.36660.16863.19571.49553.49266.42665.67178.27246.36452.38147.0361.74244.86545.4735.56852.37552.375
Operating Income Ratio 0.3080.240.4020.2890.2480.1510.2390.2540.2680.2260.2750.290.3110.2190.2420.2350.290.2380.2350.1820.2690.269
Total Other Income Expenses Net -70.068-48.553-58.968-35.0012.009-27.964-438.67-21.179-9.343-8.2257.915-6.4282.688-11-39.3427.7164.53-2.523-23.097-13.51-36.644-36.644
Income Before Tax 15.14211.01465.670.4734.4855.402-378.50242.01648.10845.26758.73441.10361.79714.082-35.078-0.58411.022-14.22-20.867-11.51215.73215.732
Income Before Tax Ratio 0.0550.0440.2120.0020.1350.024-1.5040.1690.180.1910.2430.1820.2450.066-0.162-0.0030.052-0.076-0.108-0.0590.0810.081
Income Tax Expense 6.3884.69126.98914.1310.9722.56-58.78316.92617.6914.62622.73713.65919.1823.0178.308-1.2133.77-12.2346.879-5.9629.2969.296
Net Income 8.7546.32338.681-13.6623.5132.842-319.71925.0930.41830.64135.99727.44442.59910.842-43.680.017.017-1.964-27.9-5.6356.3436.343
Net Income Ratio 0.0320.0250.125-0.0520.0920.013-1.2710.1010.1140.1290.1490.1210.1690.051-0.20100.033-0.01-0.144-0.0290.0330.033
EPS 0.0310.0220.14-0.0490.0830.01-1.140.090.110.110.130.10.150.04-0.1700.029-0.008-0.1-0.020.0270.027
EPS Diluted 0.0310.0220.14-0.0490.0830.01-1.140.090.110.110.130.10.150.04-0.1700.029-0.008-0.1-0.020.0270.027
EBITDA 125.676100.639166.09191.44581.77550.84678.017101.011107.9592.50889.98103.998118.49766.79772.48186.276101.13477.73884.57277.73989.66689.666
EBITDA Ratio 0.4540.4060.5350.3470.320.2310.310.4060.4050.3910.3730.460.470.3150.3340.4310.4750.4130.4370.3980.460.46